药物涂层球囊血管成形术单独应用与定向斑块旋切术联合药物涂层球囊血管成形术在下肢外周动脉疾病伴间歇性跛行患者中的比较
该回顾性研究纳入226例下肢外周动脉疾病患者,比较单独药物涂层球囊(DCB)血管成形术(A组)与定向斑块旋切术(DA)联合DCB(B组)。B组24个月时严重跛行发生率显著低于A组(2.8% vs 12.4%,P=0.035),12个月完全通畅率分布显著更高,作者认为旋切联合DCB在长期治疗中更优。
要点
- B组24个月严重跛行发生率3例(2.8%)显著低于A组13例(12.4%)(P=0.035)。
- B组12个月完全通畅率分布显著高于A组,A组70-100%狭窄率显著更高。
- 两组主要通畅率、2年无病生存率及随访丢失与死亡分布相似。
核心结论
- 作者认为定向斑块旋切术联合药物涂层球囊血管成形术在下肢外周动脉疾病的长期治疗中优于单独药物涂层球囊血管成形术。
研究设计与样本
- 回顾性病历审查,纳入4年间接受单独药物涂层球囊血管成形术(A组)或定向斑块旋切术联合药物涂层球囊血管成形术(B组)的下肢外周动脉疾病患者,共评估226例。
- 纳入对象为严重及闭塞性下肢外周动脉疾病患者,记录人口学数据、动脉粥样硬化血管特征和手术数据,并报告技术成功率、手术成功率和临床成功率。
主要发现
- 基线特征中仅吸烟和高脂血症在B组更高(P=0.001和P=0.010)。
- 踝肱指数在第1、3、6、12或24个月随访时无显著差异;Rutherford分级在第1、3、6或12个月无显著差异,但24个月时存在显著差异。
- A组严重跛行发生率显著高于B组(A组13例[12.4%] vs B组3例[2.8%],P=0.035)。
- B组预扩张后狭窄率显著高于A组(A组54.56±5.36 vs B组59.20±6.21,P=0.012)。
- B组第12个月完全通畅分布显著高于A组,A组第12个月70-100%狭窄率显著高于B组;两组随访丢失与死亡分布、次要结果、主要通畅率和2年无病生存率相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of the study was to compare drug-coated balloon (DCB) angioplasty alone and directional atherectomy (DA) combined with DCB angioplasty in patients with lower extremity peripheral arterial disease (LE-PAD). METHODS: Subjects treated with DCB angioplasty alone (group A) and DA combined with DCB angioplasty (group B) were enrolled in the study. A retrospective chart review was performed between the 4 years. Subjects with severe and occluded LE-PAD were included. Demographic data, atherosclerotic vessel properties, and procedural data were recorded. For both groups, success rates (technical, procedural, and clinical) were presented. RESULTS: In total, 226 patients were evaluated. For baseline characteristics, only tobacco use and hyperlipidemia were higher in group B (P = 0.001 and P = 0.010, respectively). For the ankle-brachial index, no significant difference existed at the first, third, sixth, 12th or 24th month follow-ups. No significant difference existed for the Rutherford class at the first, third, sixth, or 12th months according to the groups. A significant difference was found at 24-month Rutherford levels. The incidence of severe claudication in group A was significantly higher than that in group B (13 [12.4%] for group A and 3 [2.8%] for group B, P = 0.035). The stenosis rate after predilatation in group B was significantly higher than that in group A (54.56 ± 5.36 for group A and 59.20 ± 6.21 for group B, P = 0.012). The distribution of full patency in the 12th month in group B was significantly higher than that in group A. The rate of 70-100% stenosis in the 12th month was significantly higher in group A than in group B. According to the groups, the distribution of the patients who were lost to follow-up and died during the follow-up and secondary results, primary patency rates, and 2-year disease-free survival rates were also similar. CONCLUSIONS: Atherectomy combined with DCB is superior for the long-term treatment of LE-PAD.
引用
- Kavala AA, Kuserli Y, Turkyilmaz G, et al. Comparison of Drug-Coated Balloon Angioplasty Alone and Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty in Patients with Lower Extremity Peripheral Arterial Disease with Claudication. Ann Vasc Surg. 2022. PMID: 36404474. doi:10.1016/j.avsg.2022.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。